Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1956 May 15;74(10):802–807.

Ansolysen in the Treatment of Arterial Hypertension *,

Andre Davignon, Guy Lemieux, Jacques Genest
PMCID: PMC1824342  PMID: 13316673

Full text

PDF
802

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGREST A., HOOBLER S. W. Long-term management of hypertension with pentolinium tartrate (ansolysen). J Am Med Assoc. 1955 Mar 19;157(12):999–1003. doi: 10.1001/jama.1955.02950290019006. [DOI] [PubMed] [Google Scholar]
  2. AGREST A., HOOBLER S. W. Long-term management of hypertension with pentolinium tartrate (ansolysen). J Am Med Assoc. 1955 Mar 19;157(12):999–1003. doi: 10.1001/jama.1955.02950290019006. [DOI] [PubMed] [Google Scholar]
  3. BAIN C. W. C., ASHTON F., JONES B. P. The treatment of essential hypertension with pentolinium tartrate combined with Rauwolfia alkaloids. Br Med J. 1955 Apr 2;1(4917):817–818. doi: 10.1136/bmj.1.4917.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DOYLE A. E., KILPATRICK J. A. Methonium compounds in the angina of hypertension. Lancet. 1954 May 1;266(6818):905–908. doi: 10.1016/s0140-6736(54)91525-1. [DOI] [PubMed] [Google Scholar]
  5. FREIS E. D., PARTENOPE E. A., LILIENFIELD L. S., ROSE J. C. A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients. Circulation. 1954 Apr;9(4):540–546. doi: 10.1161/01.cir.9.4.540. [DOI] [PubMed] [Google Scholar]
  6. GENEST J., ROBILLARD R., TREMBLAY G., ADAMKIEWICZ L. L'administration de l'hexamethonium chez les patients souffrant d'hypertension maligne. Union Med Can. 1954 Nov;83(11):1210–1217. [PubMed] [Google Scholar]
  7. MAXWELL R. D. H., CAMPBELL A. J. M. New sympathicolytic agents. Lancet. 1953 Mar 7;1(6758):455–457. doi: 10.1016/s0140-6736(53)91639-0. [DOI] [PubMed] [Google Scholar]
  8. PATON W. D. M., ZAIMIS E. The methonium. Pharmacol Rev. 1952 Sep;4(3):219–253. [PubMed] [Google Scholar]
  9. SMIRK F. H. Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene 1:5-bis-N-(N-methylpyrrolidinium) bitartrate (M. & B. 2050A). N Z Med J. 1953 Oct;52(291):325–348. [PubMed] [Google Scholar]
  10. WIEN R., MASON D. F. J. Pharmacology of M. & B. 2050. Lancet. 1953 Mar 7;1(6758):454–455. doi: 10.1016/s0140-6736(53)91638-9. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES